ER+/HER2+ Metastatic Breast Cancer
2 Visninger
• 07/03/23
0
0
Indlejre
administrator
Abonnenter
Hope S. Rugo, MD, looks at the use of CDK4/6 inhibitors for patients with metastatic ER-positive, HER2-positive breast cancer and the trials evaluating their use in this setting.
Vis mere
Facebook kommentarer
SORT BY-
Topkommentarer
-
Seneste kommentarer